Cargando…
Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study
INTRODUCTION: People living with HIV (PLWH) who engaged in chemsex are at risk of potential drug–drug interactions (pDDIs) with recreational drugs. This study aimed to characterize pDDIs between antiretroviral treatment (ART) and chemsex drugs and evaluate their association with unscheduled relevant...
Autores principales: | De La Mora, Lorena, Nebot, María J., Martinez-Rebollar, Maria, De Lazzari, Elisa, Tuset, Montserrat, Laguno, Montserrat, Ambrosioni, Juan, Miquel, Laia, Blanch, Jordi, Ugarte, Ainoa, Torres, Berta, González-Cordón, Ana, Inciarte, Alexy, Chivite, Iván, Short, Duncan, Salgado, Emilio, Martinez, Esteban, Blanco, José L., Mallolas, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669299/ https://www.ncbi.nlm.nih.gov/pubmed/36173594 http://dx.doi.org/10.1007/s40121-022-00694-w |
Ejemplares similares
-
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life—Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain
por: De La Mora, Lorena, et al.
Publicado: (2022) -
Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study
por: De La Mora, Lorena, et al.
Publicado: (2023) -
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience
por: Ugarte, Ainoa, et al.
Publicado: (2022) -
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)
por: Inciarte, Alexy, et al.
Publicado: (2023) -
Chemsex, G&T, and The Club Drugs Clinic Ireland
por: Santlal, K., et al.
Publicado: (2022)